HLN vs KVUE vs PG vs CL

For growth investors, Colgate-Palmolive Company (CL) is the stronger pick with 1.

4% revenue growth year-over-year, versus -4. 0% for Haleon plc (HLN). Haleon plc (HLN) offers the better valuation at 19. 0x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Haleon plc (HLN) is the cheapest at 19.

0x versus Colgate-Palmolive Company at 33. 2x. On forward P/E, Kenvue Inc. is actually cheaper at 15. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haleon plc wins at 2. 63x versus The Procter & Gamble Company's 3. 78x.

Over the past 5 years, Haleon plc (HLN) delivered a total return of +31.

7%, compared to -25. 7% for Kenvue Inc. (KVUE). Over 10 years, the gap is even starker: PG returned +119. 3% versus KVUE's -25. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.

00β versus Kenvue Inc. 's 0. 24β — meaning KVUE is approximately -5618% more volatile than CL relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Colgate-Palmolive Company (CL) is pulling ahead at 1.

4% versus -4. 0% for Haleon plc (HLN). On earnings-per-share growth, the picture is similar: Kenvue Inc. grew EPS 40. 7% year-over-year, compared to -25. 1% for Colgate-Palmolive Company. Over a 3-year CAGR, CL leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 9. 7% for Kenvue Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 17. 9% for KVUE. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Haleon plc (HLN) is the more undervalued stock at a PEG of 2. 63x versus The Procter & Gamble Company's 3. 78x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Kenvue Inc. (KVUE) trades at 15. 6x forward P/E versus 22. 9x for Colgate-Palmolive Company — 7. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.

All stocks in this comparison pay dividends.

Kenvue Inc. (KVUE) offers the highest yield at 4. 6%, versus 1. 9% for Haleon plc (HLN).

For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

00), 2. 6% yield). Both have compounded well over 10 years (CL: +47. 0%, KVUE: -25. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HLN (Healthcare) and KVUE (Consumer Defensive) and PG (Consumer Defensive) and CL (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLN is a mid-cap quality compounder stock; KVUE is a mid-cap income-oriented stock; PG is a large-cap quality compounder stock; CL is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.